Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Recommended Global Cardiology Webinars & Conferences

Asia Pacific & Middle East
Canada

Hypertension Congress-2026

About Conference


The 13th World Congress on Hypertension, Cardiology, Primary Health, and Patient Care is a premier international event uniting healthcare professionals, researchers, clinicians, and industry leaders to explore the most recent developments in cardiovascular medicine, hypertension management, and innovations in primary care.
 
Organized by Conference Series, in collaboration with leading medical associations and academic institutions, the congress will be held in the charming city of Paris, France, from May 21–22, 2026.
 
This two-day scientific forum aims to promote evidence-based discussions, foster cross-disciplinary collaborations, and empower clinicians and researchers with new tools, strategies, and technologies that elevate global cardiovascular and primary healthcare.

 

Conference Theme: “Innovations in Cardiovascular and Primary Care: From Prevention to Personalized Medicine”

Why Attend?
  • Connect with Global Experts: Interact with leading cardiologists, primary care physicians, hypertension specialists, and public health professionals from around the world.
  • Explore Cutting-Edge Research: Gain insights into the latest studies, clinical trials, and case reports on heart failure, coronary artery disease, arrhythmias, and more.
  • Advance Patient-Centered Care: Discover how to integrate personalized care models and digital health tools into clinical practice for improved outcomes.
  • Enhance Professional Skills: Attend CME-accredited lectures, interactive workshops, and panel discussions led by global authorities in cardiovascular health.
  • Network & Collaborate: Build meaningful relationships with academic institutions, healthcare startups, pharma companies, and regulatory agencies.
Conference Highlights
  • Keynote Addresses by renowned cardiovascular scientists and global health policy leaders
  • Workshops & Hands-on Training in ECG interpretation, blood pressure monitoring, and AI-powered diagnostics
  • Young Researchers Forum & Poster Presentations showcasing emerging talent and innovations
  • Industry Exhibition Booths featuring leading healthcare and MedTech innovations
Who Should Attend?
  • Cardiologists and Cardiac Surgeons
  • Hypertension Specialists and Endocrinologists
  • General Practitioners and Family Physicians
  • Internists and Primary Care Providers
  • Researchers and Academicians in Cardiology and Public Health
  • Clinical Pharmacologists and Healthcare Technologists
  • Public Health Officials and Epidemiologists
  • Medical Students, Nurses, and Allied Health Professionals

 

Scientific Sessions

We invite all researchers, healthcare professionals, academicians, and industry leaders to submit abstracts under the following high-impact and timely scientific tracks. Present your work, share your expertise, and engage in groundbreaking discussions at the 13th World Congress on Hypertension, Cardiology, Primary Health and Patient Care, taking place on May 21–22, 2026, in Paris, France.
 
Present innovative strategies in blood pressure regulation, resistant hypertension, and integrated lifestyle-based interventions.
 
Showcase novel diagnostics, therapeutic breakthroughs, and interventional cardiology innovations that are reshaping modern practice.
 
Discuss models of integrated care, community health strategies, and early detection tools aimed at reducing cardiovascular disease burden.
 
Explore recent developments in HFpEF and HFrEF management, biomarkers, and emerging treatment modalities for advanced heart failure.
 
Share research on lipid-lowering strategies, cutting-edge stenting technologies, and advanced risk stratification methods.
 
Present advances in atrial fibrillation management, pacemaker technology, ICD deployment, and catheter ablation techniques.
 
Examine the interplay of diabetes, obesity, dyslipidemia, and hypertension in cardiovascular risk profiling and patient management.
 
Discuss gender-specific variations in cardiovascular disease presentation, diagnostic challenges, and outcomes-based care.
 
Highlight age-related cardiovascular issues, polypharmacy, frailty, and transitions of care in aging populations.
 
Showcase breakthroughs in fetal cardiology, pediatric interventional procedures, and long-term congenital heart disease care.
 
Present advancements in echocardiography, cardiac MRI, CT angiography, nuclear cardiology, and AI-driven diagnostic platforms.
 
Explore the latest in TAVI, PCI, hybrid revascularization techniques, and robotic-assisted cardiac surgeries.
 
Discuss the clinical impact of nutrition, exercise, stress management, and behavioral change in cardiovascular prevention.
 
Highlight emerging technologies in remote monitoring, AI-enabled diagnostics, and telecardiology for accessible and efficient care.
 
Share insights into novel antihypertensives, antithrombotic therapies, lipid-lowering agents, and next-generation cardiovascular drugs.
 
Discuss pre-hospital care strategies, CPR advancements, STEMI/ACS protocol optimization, and emergency response systems.
 
Evaluate updates to international clinical guidelines and their real-world implications for daily cardiology practice.
 
Promote models of care that emphasize patient engagement, adherence, personalized counseling, and health literacy.
 
Investigate cardiovascular complications arising from cancer therapy and best practices in cardio-oncology management.
 
Share findings from population health studies, policy-driven interventions, and national cardiovascular screening initiatives.
 
Explore how AI, machine learning, and big data analytics are transforming diagnosis, risk prediction, and clinical workflows.
 
Present findings or protocols from clinical trials focused on drug efficacy, device performance, and cardiovascular outcomes.
 
Discuss evidence-based practices in herbal medicine, acupuncture, yoga, and mind-body therapies supporting cardiovascular health.
 
Analyze how workplace stress, air pollution, and environmental noise contribute to cardiovascular risk and disease progression.
 
Envision the next decade in cardiovascular care, from precision medicine and genomics to wearable health tech and patient-centric models.

Call for Abstracts — Submit Now!
We encourage all interested professionals to submit abstracts aligned with the above scientific sessions. This is a unique opportunity to contribute to global cardiovascular knowledge, foster collaborations, and inspire innovation.

Abstract Submission Guidelines

Call for Abstracts: Submit Your Research at the Premier Hypertension and Cardiology Conference 2026
The 13th World Congress on Hypertension, Cardiology, Primary Health and Patient Care invites researchers, clinicians, academicians, and healthcare professionals worldwide to submit abstracts for oral and poster presentations. This international conference provides a leading platform to share original research, clinical trials, case reports, and innovative solutions in hypertension management, cardiovascular disease, and primary healthcare.
 
Who Should Submit?
  • Cardiologists, cardiac surgeons, and hypertension specialists
  • Primary care physicians and family medicine practitioners
  • Clinical researchers and medical trial investigators
  • Public health experts and epidemiologists
  • Healthcare technology innovators and digital health specialists
  • Medical students, residents, and trainees
Accepted Abstract Formats
  • Original research articles
  • Clinical case studies and patient care reports
  • Systematic reviews and meta-analyses
  • Pilot studies and clinical trial results
  • Innovative diagnostic and treatment techniques
  • Epidemiological and public health studies
  • Technological advances in cardiovascular and primary care
Abstract Preparation Guidelines
  • Title: Clear, concise, and keyword-rich (max 20 words).
  • Authors: Full names with affiliations; underline presenting author.
  • Abstract Body: Structured as Background, Methods, Results, and Conclusion (300–350 words).
  • Keywords: Include 4 to 6 relevant keywords focusing on hypertension, cardiology, or primary care.
  • Language: English only.
  • Formatting: Use standard fonts (Arial or Times New Roman, 12 pt), avoid tables/images, define abbreviations.
Submission Process
  • Submit abstracts online at: https://hypertensioncongress.cardiologymeeting.com/abstract-submission.php
  • Select the appropriate scientific track from the conference sessions.
  • Abstracts must present original, unpublished work.
  • Ethical compliance and patient confidentiality must be maintained.
  • One abstract per presenting author is permitted.
  • Acceptance notifications are sent within 1-2 days of submission.
Presentation Options
  • Oral Presentations: For novel research with significant clinical impact.
  • Poster Presentations: For case reports, preliminary studies, and ongoing research.
  • Workshops: Interactive sessions focusing on hands-on training, clinical skills development, and innovative techniques in hypertension, cardiology, and primary healthcare.
  • Virtual Presentations: Available for international participants; prior approval required.
Benefits of Abstract Submission
  • Present your work at a high-profile international cardiology and hypertension conference.
  • Network with leading clinicians, researchers, and healthcare professionals.
  • Get your abstract published in the official conference proceedings with ISBN/ISSN.
  • Gain eligibility for best abstract awards and publication opportunities in indexed journals.

Visa Information

If you are planning to attend the 13th World Congress on Hypertension, Cardiology, Primary Health and Patient Care in Paris, France, it is essential to understand the visa requirements and application process to ensure a smooth and hassle-free travel experience.
 
Do You Need a Visa to Enter France?
  • France is a member of the Schengen Area, which allows visitors from many countries to enter with a Schengen Visa for short-term stays up to 90 days. Whether you require a visa depends on your nationality:
  • Visa-Exempt Countries: Citizens of the European Union (EU), United States, Canada, Australia, Japan, and several others do not require a visa for short visits.
  • Visa-Required Countries: Nationals from countries such as India, China, Russia, Nigeria, Brazil, and others must apply for a Schengen Short-Stay Visa prior to arrival.
Types of Visas Suitable for Conference Attendance

Schengen Short-Stay Visa (Type C): Ideal for business and conference attendance, valid for up to 90 days within a 180-day period.
 
Long-Stay Visa (Type D): If your stay extends beyond 90 days for research or academic purposes, this visa category applies.
 
How to Apply for a Schengen Visa for France
  1. Locate Your Nearest French Consulate or Visa Application Center
    Find the official French consulate or embassy website in your country for specific application instructions.
  2. Gather Required Documents:
  • Valid passport with at least six months validity beyond your stay
  • Completed and signed visa application form
  • Recent passport-sized photographs as per Schengen guidelines
  • Official conference invitation letter from the 13th World Congress on Hypertension, Cardiology, Primary Health and Patient Care organizers
  • Proof of accommodation in Paris (hotel booking or invitation letter)
  • Round-trip flight reservation
  • Travel medical insurance covering at least €30,000 for emergency medical treatment and repatriation
  • Proof of sufficient financial means for the duration of your stay
  • Employment or student status proof (if applicable)

Schedule an Appointment and Submit Your Application

  • Submit your application in person at the consulate or visa application center, along with biometric data if required.

Pay the Visa Fee

  • Standard Schengen visa fees apply (approximately €80 for adults).

Wait for Processing

  • Visa processing generally takes 15 calendar days but may vary based on consulate workload.
Important Tips for Visa Applicants
  • Apply Early: Start your visa application at least 4-6 weeks before the conference dates to avoid last-minute delays.
  • Use the Official Invitation Letter: The conference organizers will provide an official invitation letter upon your registration confirmation to support your visa application.
  • Check COVID-19 Travel Requirements: Stay updated on any health or quarantine protocols required by France at the time of travel.
  • Travel Insurance: Ensure your insurance policy covers the entire Schengen zone and duration of your stay.

Be a Sponser/Exhibitor

Unlock unparalleled opportunities to showcase your brand and connect with a global audience of healthcare professionals, cardiologists, hypertension specialists, researchers, and primary care providers at the forefront of cardiovascular medicine. The 13th World Congress offers a prestigious platform for sponsors and exhibitors to demonstrate cutting-edge innovations, products, and services shaping the future of hypertension management, cardiology treatments, and primary health care.
 
Why Sponsor or Exhibit?
 
Global Exposure: Reach thousands of international delegates, including cardiology experts, clinical researchers, healthcare innovators, and policy makers.
 
Targeted Networking: Build strategic partnerships with top-tier professionals, pharmaceutical companies, medical device manufacturers, and healthcare organizations.
 
Brand Visibility: Elevate your corporate identity through high-impact branding opportunities, including keynote sponsorships, workshop hosting, and exhibition booths in a high-traffic venue.
 
Lead Generation: Showcase your latest cardiovascular diagnostics, therapeutic devices, digital health solutions, and preventive care technologies to decision-makers eager to adopt new advancements.
 
Thought Leadership: Position your organization as an industry leader by engaging with thought-provoking discussions, panel sessions, and innovation showcases aligned with personalized medicine and preventive cardiology.
 
Sponsorship Packages Include:
  • Prominent logo placement on congress materials and website
  • Dedicated exhibition space with customizable booth design
  • Complimentary registrations for company representatives
  • Opportunity to host sponsored sessions and workshops
  • Access to delegate lists for pre- and post-event marketing
  • Exclusive branding in networking lounges, refreshment zones, and digital platforms
Join us in Paris, a global hub for medical innovation, to drive impactful collaborations and accelerate breakthroughs in hypertension, cardiology, and primary health care. Together, we can transform cardiovascular health through cutting-edge research, innovative treatments, and comprehensive patient care.
 
Become a Sponsor or Exhibitor Today!
For detailed sponsorship and exhibition packages, customized branding opportunities, and partnership inquiries, please contact our Sponsorship Team at contact@europeanmeets.com or visit our official website.

Market Analysis

The 13th World Congress on Hypertension, Cardiology, Primary Health and Patient Care offers a strategic platform to assess global market trends, emerging technologies, and investment opportunities in the interconnected fields of hypertension management, cardiovascular health, and primary care services. As the global burden of non-communicable diseases (NCDs) continues to escalate, this congress serves as a nexus for industry leaders, healthcare professionals, researchers, and policy-makers to explore innovative strategies and collaborative solutions.
 
Global Burden and Growth Trends
  • Hypertension affects over 1.28 billion adults globally, with a majority unaware of their condition. The increasing prevalence is fueling demand for innovative antihypertensive therapies, remote monitoring solutions, and digital health tools.
  • The cardiology market is projected to reach USD 70.8 billion by 2030, growing at a CAGR of 6.2% (source: Market Research Future). This growth is driven by advances in interventional cardiology, AI-powered diagnostics, and wearable cardiac monitors.
  • The primary healthcare sector is witnessing massive transformation with a shift toward integrated care models, telemedicine, and value-based healthcare, creating a robust market for e-health and chronic disease management solutions.
Key Market Drivers
  • Aging Population: Rising geriatric demographics globally are increasing the incidence of cardiovascular diseases and chronic conditions.
  • Technological Innovations: Emergence of AI in diagnostics, personalized medicine, and digital health platforms are reshaping patient care.
  • Policy Reforms & Government Initiatives: Efforts to improve universal health coverage, particularly in low- and middle-income countries, are amplifying the focus on preventive cardiology and primary care access.
  • Rising Health Awareness: Growing public awareness about heart health and lifestyle-related disorders is boosting market demand for early detection tools and wellness programs.
Opportunities for Stakeholders
  • Pharmaceutical Companies: Showcase latest drug pipelines for hypertension, lipid disorders, and heart failure.
  • Medical Device Manufacturers: Present innovations in blood pressure monitors, stents, pacemakers, and remote monitoring devices.
  • Healthcare Startups: Explore partnerships and funding in AI diagnostics, tele-cardiology, and patient management platforms.
  • Academia and Research Institutions: Engage with top minds to discuss clinical research breakthroughs and future therapeutic pathways.
  • Policy-Makers and NGOs: Collaborate on strategies to improve global cardiovascular health and equitable access to primary care.
Regional Market Insights
  • Europe leads in cardiovascular research and clinical trials, making Paris an ideal host city.
  • North America holds the largest share in global cardiology and hypertension markets due to advanced infrastructure and high R&D investment.
  • Asia-Pacific is emerging rapidly with growing healthcare investments, government-backed screening programs, and digital health adoption.
Why This Congress Matters

The 13th World Congress on Hypertension, Cardiology, Primary Health and Patient Care is not just a scientific event—it is a global marketplace of ideas, technologies, and collaborations. Participants will gain insights into the latest market dynamics, explore business development prospects, and shape the future of heart and primary healthcare through innovation and partnerships.

To Collaborate Scientific Professionals around the World

Conference Date May 21-22, 2026

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

Journal of Hypertension: Open Access Journal of Patient Care Primary Health Care: Open Access

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by


Keytopics

  • Acute Coronary Syndromes
  • Arrhythmias And Conduction Disorders
  • Artificial Intelligence In Cardiology
  • Atherosclerosis And Lipid Disorders
  • Big Data In Cardiovascular Research
  • Biomarkers In Cardiovascular Diseases
  • Blood Pressure Monitoring Techniques
  • Cardiac Imaging Techniques
  • Cardiac Rehabilitation
  • Cardiac Surgery
  • Cardio-oncology
  • Cardiomyopathies
  • Cardiovascular Pharmacology
  • Cardiovascular Risk Factors
  • Chronic Disease Management
  • Clinical Trials In Cardiology
  • Community-based Health Interventions
  • Congenital Heart Disease
  • Coronary Artery Disease
  • Digital Health Technologies In Primary Care
  • Electrophysiology
  • Essential Hypertension
  • Ethics In Cardiovascular Care
  • Exercise And Heart Health
  • Family Medicine And General Practice
  • Gender Differences In Cardiovascular Disease
  • Genetics Of Cardiovascular Diseases
  • Geriatric Cardiology
  • Global Health And Non-communicable Diseases
  • Health Education And Promotion
  • Health Policy And Primary Care
  • Heart Failure
  • Hypertension And Diabetes
  • Hypertension And Its Management
  • Hypertension In Pregnancy
  • Hypertensive Emergencies
  • Integrated Primary Health Care
  • Interventional Cardiology
  • Key Topics
  • Lifestyle Modifications For Hypertension
  • Mental Health In Primary Care
  • Non-invasive Cardiology
  • Novel Drug Therapies In Cardiology
  • Nursing In Primary Health Care
  • Nutrition And Cardiovascular Health
  • Obesity And Cardiovascular Risk
  • Patient Adherence And Compliance
  • Patient-centered Care
  • Pediatric Hypertension
  • Pharmacological Treatments For Hypertension
  • Preventive Cardiology
  • Preventive Health Screenings
  • Primary Health Care Systems
  • Pulmonary Hypertension
  • Resistant Hypertension
  • Secondary Hypertension
  • Sleep Apnea And Cardiovascular Risk
  • Smoking Cessation Programs
  • Stroke And Hypertension
  • Telecardiology And EHealth
  • Valvular Heart Diseases